Medtecs International Corporation Limited (9103) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medtecs International Corporation Limited (9103:TWSE), powered by AI.

Current Price
$5.46
P/E Ratio
-624.4
Market Cap
3.0B
Sector
Healthcare
What is the Medtecs International Corporation Limited stock price forecast?

Medtecs International Corporation Limited is currently trading at $5.46. View real-time AI analysis on Alpha Lenz.

What is Medtecs International Corporation Limited insider trading activity?

View the latest insider trading data for Medtecs International Corporation Limited on Alpha Lenz.

What is Medtecs International Corporation Limited's P/E ratio?

Medtecs International Corporation Limited's P/E ratio is -624.4.

Medtecs International Corporation Limited

TWSE · 9103
NT$5.46-0.16(-2.85%)
Ask about Medtecs International Corporation Limited's future dividend policy...
Alpha Chat Insight

Medtecs International Corporation Limited trades at a P/E of -624.4 (undervalued) with modest ROE of -4.6%.

Ask for details

Company Overview

Medtecs International Corporation Limited is a leading integrated manufacturer and distributor of healthcare and personal protective equipment based in Asia. Since its founding in 1989, the company has specialized in producing high-quality medical and industrial textiles, including isolation gowns, coveralls, and surgical masks, crucial for ensuring the safety and protection of healthcare workers and patients. Medtecs' products are vital for sectors such as healthcare, industrial safety, and emergency response, underscoring their role in critical supply chains. The company has established a robust distribution network across the globe, servicing clients in Europe, Asia-Pacific, and the United States. By continuously enhancing their manufacturing processes and product offerings, Medtecs plays a significant role in supporting global public health infrastructure and readiness, particularly highlighted during health crises when demand for protective equipment surges. The company's commitment to innovation and quality supports its position as a trusted partner in the healthcare industry, contributing significantly to the safety supplies market worldwide.

CEOMr. Weiyuan Yang
SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

NT$2.98BMarket Cap
NT$78.97MRevenue
0.00Shares Out
0Employees

Margins

16.01%Gross
2.89%EBITDA
-7.92%Operating
-6.51%Pre-Tax
-6.03%Net

Valuation

-624.39P/E
29.30P/B
37.68EV/Sales
1307.27EV/EBITDA
-328.86P/FCF

Growth (CAGR)

-64.08%Rev 3Yr
-64.04%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-3.36%ROA
-4.59%ROE
-3.08%ROIC

Financial Health

NT$15.50MCash & Cash Equivalents
NT$28.19MNet Debt
42.82%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Medtecs International Corporation Limited (ticker: 9103) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies). Market cap is $3.0B.

The current price is 5.46 with a P/E ratio of -624.39x and P/B of 29.3x.

ROE is -4.59% and operating margin is -7.92%. Annual revenue is $79M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Medtecs International Corporation Limited (9103) Stock Forecast 2026 $5.46 — Price, Financials & Analyst Targets | Alpha Lenz